James Samuel Shannon - 29 Sep 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Director
Signature
/s/ Meghanne Downes, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
29 Sep 2023
Net transactions value
+$144,452
Form type
4
Filing time
02 Oct 2023, 19:25:50 UTC
Previous filing
28 Jul 2023
Next filing
06 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $144,452 +11,850 +56% $12.19 33,156 29 Sep 2023 Direct
holding HZNP Ordinary Shares 23,638 29 Sep 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (right to buy) Options Exercise $0 -11,850 -59% $0.000000 8,150 29 Sep 2023 Ordinary Shares 11,850 $12.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested.